Get started
DYNAVAX TECHNOLOGIES CORP COM USD0.001DYNAVAX TECHNOLOGIES CORP COM USD0.001DYNAVAX TECHNOLOGIES CORP COM USD0.001

DYNAVAX TECHNOLOGIES CORP COM USD0.001

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

0IDA trade ideas

$DVAX Dynavax To update on Covid Vaccine Tuesday In a regulatory 8-k filing released earlier, the company states: "In meetings with securities analysts and investors to be held on May 19, 2020 in connection with a vaccine investor day, Dynavax intends to provide an update on its early-stage collaborations regarding the potential development of a vaccine for COVID-19 containing the company's proprietary toll-like receptor 9 agonist adjuvant CpG-1018, the adjuvant used in the Company's HEPLISAV-B product. The update is that the company expects that one or more of its collaboration partners will commence a Phase 1 clinical trial of a potential COVID-19 vaccine as soon as July 2020."
NASDAQ:DVAXLong
by RedHotStocks
$DVAX can rise in the next daysContextual immersion trading strategy idea. Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. The demand for shares of the company looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $3,94; stop-loss — $3,80. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:DVAXLong
by KozakHlib
Three Pecent Trade Idea: Go long DVAXHere is a great opportunity to go long on DVAX . This stock is very different from what we would typically recommend or trade. This is a biopharmaceutical company and the risk is much higher. We believe in this range you can get an outstanding risk/reward ratio. This does really have the potential to go over 100% from current levels. This is similar to the last 2 bio plays: TGTX: $5.44 Entry - Currently trading over $15 MYOV: $4.44 Entry - Currently trading over $12 (Sold at $16)
NASDAQ:DVAXLong
by ThreePercentTrades
2019 Looks Bright, SD-101 should send stocks soaringDynavax recently presented a company outlook for 2019 at the JP Morgan Healthcare Conference. During the presentation, CEO Eddie Gray revealed encouraging HEPISLAV-B sales for Q4 of ~$3.7M. 2018 was a big year for Dynavax's lead immuno-oncology candidate SD-101. The company has stated they are looking for a potential partner for their planned Phase III in melanoma. The stock experienced a strong sell-off in Q4, but the new year should treat DVAX well. In its March 2019 Cowen presentation, Dynavax issued a pipeline slide. Although I note a lack of phase 3 candidates. It has but a single therapy, SD-101, in phase 2 that it is advancing in combination with Merck's Keytruda (pembrolizumab) in various combinations. Positive news from SD-101 should send stocks soaring.
NASDAQ:DVAXLong
by warrenhochfeld
Watch for channel breakoutFirst of all, beware of a false breakout by sharks trying to get you to go long; Basically they make it look like its breaking out of the channel but then it retracts, falls into the channel and goes to the lower end of the channel; anyways, i'm looking for the breakout; im less risk averse, so i'll be willing to take the long after two days of it remainng outside the channel. So if it breaks out today, closes above the channel tomorrow and the next day; then safe to say it can truly breakout and start a new upward channel.
NASDAQ:DVAXLong
by yousufj56
DVAX - Aggressive Swing TradeThis is an aggressive swing trade that I will be placing early Monday unless the markets look extremely bearish. I am calling this an aggressive trade because of the obvious roadblocks that it will need to overcome in order to reach the target. Also because If I am triggered into the trade and it moves in my favor I will be quickly moving my stop loss up to mitigate my risk as soon as possible just in case one of the roadblocks does, in fact, prove to be insurmountable. Here are the things I like about this trade 1) The price is bouncing off of the 200 SMA 2) The last 3 candles have formed a morning star reversal pattern Here are the potential roadblocks facing this trade 1) The price must break through a fairly strong looking resistance in order to reach the target. 2) The 100 SMA is dropping and will most likely pose a strong resistance as it has in the past. Here is my set up 1) My Bullish stop limit - place the buy stop at $16.75 and the limit at $16.78 2) My stop loss will be placed at $15.55 and my 2R profit target will be at $19.15
NASDAQ:DVAXLong
by Bigsky_Crypto
1